Biological risks do not respect borders, and therefore the safeguards designed to prevent them need to cross borders, as well. Aligning sequence-screening standards internationally is essential to closing gaps, building trust between countries, and ensuring that advances in biotechnology strengthen global security rather than undermine it.

Bob Mikulak recently served in senior advisory roles at the U.S. Department of State, where he worked at the intersection of international security, nonproliferation, and emerging technologies. His portfolio included engagement on global norms and multilateral frameworks related to biological and chemical risks, arms control, and the governance of dual-use science and technology.

With extensive experience in diplomatic coordination and international policy development, Bob has been closely involved in efforts to strengthen global approaches to biosecurity, including alignment across national systems, engagement with international organizations, and dialogue between governments, industry, and the scientific community. His work reflects a deep understanding that effective biosecurity in the age of synthetic biology depends on shared expectations, interoperable safeguards, and sustained international cooperation.